COMMUNIQUÉS West-GlobeNewswire

Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results

07/05/2019 - 23:12

CHARLESTON, S.C., May 07, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the first quarter ended March 31, 2019. All Amounts are in U.S. [...]

Supernus Announces First Quarter 2019 Financial Results

07/05/2019 - 23:09

Total revenue of $85.5 million and net product sales of $83.1 million. Net product sales compare to $89.1 million in 2018 and were adversely impacted by approximately $10 million in channel inventory reduction in the [...]

National Research Corporation Announces First Quarter 2019 Results

07/05/2019 - 23:00

LINCOLN, Neb., May 07, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRC) today announced results for the first quarter of 2019. Net New Sales of $4.1 million Net Income increased to $8.2 million 650+ [...]

Covetrus Reschedules First Quarter 2019 Earnings Release and Conference Call to May 15 and Files Historical Pro Forma 2018 Financial Information

07/05/2019 - 22:59

PORTLAND, Maine, May 07, 2019 (GLOBE NEWSWIRE) -- Covetrus, Inc. (Nasdaq: CVET) today announced that it has rescheduled the release of its first quarter 2019 earnings results and conference call to Wednesday, May 15, [...]

Atara Biotherapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019

07/05/2019 - 22:41

SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]

Eidos Therapeutics Reports First Quarter 2019 Financial Results

07/05/2019 - 22:30

SAN FRANCISCO, May 07, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today reported its financial results for the first quarter ended March 31, 2019 and provided an update on the company’s [...]

Foamix Reports First Quarter 2019 Financial Results and Provides Corporate Update

07/05/2019 - 22:21

FDA Accepts NDA for FMX101, Sets October 20, 2019 as PDUFA Action Date Conference Call Scheduled for Wednesday May 8 th at 8:30am Eastern Time REHOVOT, Israel and BRIDGEWATER, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- [...]

OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results

07/05/2019 - 22:20

Conference call begins today at 4:30 p.m. Eastern time MIAMI, May 07, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2019 [...]

Inspire Medical Systems, Inc. Announces First Quarter 2019 Financial Results and Increases 2019 Outlook

07/05/2019 - 22:15

MINNEAPOLIS, May 07, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

AnaptysBio Announces First Quarter 2019 Financial Results and Provides Pipeline Updates

07/05/2019 - 22:15

Multiple Top-line Phase 2 Clinical Efficacy Readouts from Wholly-owned Pipeline Anticipated in 2019 Etokimab Phase 2a Severe Eosinophilic Asthma Data to be Presented at the 2019 EAACI Congress IND Filing for New Wholly- [...]

Axovant Announces Reverse Share Split Effectiveness

07/05/2019 - 22:15

Shares to begin trading on split-adjusted basis on May 8, 2019 BASEL, Switzerland, May 07, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene [...]

Progenics Pharmaceuticals Comments on Velan Capital’s Preliminary Proxy Statement

07/05/2019 - 22:15

No Shareholder Action Required at this Time NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX, “Progenics” or the “Company”), an oncology company developing innovative targeted [...]

Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology

07/05/2019 - 22:15

MORRISVILLE, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that recent data from the Company’s Phase 1b trial with SB414 cream for the treatment of atopic [...]

Abeona Therapeutics Announces Participation in Upcoming Investor Conferences

07/05/2019 - 22:15

NEW YORK and CLEVELAND, May 07, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced its participation in the following upcoming investor [...]

MyoKardia Announces Inaugural MyoSeeds™ Research Grants Program Awardees

07/05/2019 - 22:10

Three Researchers Awarded $250,000 Each to Advance Independent Research in Cardiac Diseases SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, a clinical-stage biopharmaceutical company pioneering [...]

TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019

07/05/2019 - 22:05

SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and [...]

Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update

07/05/2019 - 22:05

Net cash used in operating and investing activities was $17.6 million in the first quarter; quarter-end cash and restricted cash position of $414.2 million provides funding to advance neuroscience pipeline Initiated [...]

Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones

07/05/2019 - 22:05

– Registration-directed trial of tipifarnib in HRAS mutant HNSCC continues on track – – Data from ongoing Phase 2 trial of tipifarnib in CXCL12-driven PTCL accepted for oral presentations at EHA and ICML next month – – [...]

Kezar Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update

07/05/2019 - 22:05

Phase 1b systemic lupus erythematosus (SLE) top-line data release and Phase 2 lupus nephritis (LN) initiation on track in Q2 2019 Site selection underway for Phase 2 trial of KZR-616 for the treatment of dermatomyositis [...]